{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T09:51:39Z","timestamp":1723542699992},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10792-018-0939-6","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T14:09:31Z","timestamp":1527602971000},"page":"1391-1395","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Macula halo syndrome"],"prefix":"10.1007","volume":"39","author":[{"given":"\u0130smail Umut","family":"Onur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Memhet Fatih","family":"A\u015fula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cansu","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Mert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"939_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.survophthal.2013.02.005","volume":"59","author":"H Chen","year":"2014","unstructured":"Chen H, Chan AY, Stone DU, Mandal NA (2014) Beyond the cherry-red spot: ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders. Surv Ophthalmol 59:64\u201376","journal-title":"Surv Ophthalmol"},{"issue":"Pt 6","key":"939_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/eye.1996.168","volume":"10","author":"S Pagliarini","year":"1996","unstructured":"Pagliarini S, Pupparo S, Gharbiya M, Regine F, Babacco Gabrieli C (1996) Macula halo syndrome and non-pitting lid oedema in an Italian family. Eye (Lond) 10(Pt 6):723\u2013726","journal-title":"Eye (Lond)"},{"key":"939_CR3","unstructured":"Cogan DG, Chu FC, Barranger JA, Gregg R (1982) Macula halo syndrome. Read in part before the American ophthalmological society, Hot Springs, VA, 25 May, 1982"},{"key":"939_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0002-9394(14)75945-8","volume":"85","author":"DS Walton","year":"1978","unstructured":"Walton DS, Robb RM, Crocker AC (1978) Ocular manifestations of group a Niemann\u2013Pick disease. Am J Ophthalmol 85:174\u2013180","journal-title":"Am J Ophthalmol"},{"key":"939_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/sj.bjp.0706173","volume":"145","author":"K Lindner","year":"2005","unstructured":"Lindner K, Uhlig U, Uhlig S (2005) Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. Br J Pharmacol 145:132\u2013140","journal-title":"Br J Pharmacol"},{"key":"939_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.ophtha.2003.10.034","volume":"111","author":"MM McGovern","year":"2004","unstructured":"McGovern MM, Wasserstein MP, Aron A (2004) Ocular manifestations of Niemann\u2013Pick disease type B. Ophthalmology 111:1424\u20131427","journal-title":"Ophthalmology"},{"issue":"2","key":"939_CR7","first-page":"379","volume":"25","author":"MA Haque","year":"2016","unstructured":"Haque MA, Miah MZ (2016) Niemann\u2013Pick disease type B in a 21 year old male. Mymensingh Med J. 25(2):379\u2013381","journal-title":"Mymensingh Med J."},{"key":"939_CR8","unstructured":"Figen Bat\u0131o\u011flu, G\u00f6khan \u00d6zdemir, Leyla S. Atmaca (2001) Makula Halesi \u2018nin E\u015flik Etti\u011fi Niemann\u2013Pick Hastal\u0131\u011f\u0131 Retina-Vitreus, Cilt 9, Say\u0131 2 Sayfalar, p 161\u2013164"},{"issue":"9","key":"939_CR9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/jamaophthalmol.2013.2374","volume":"131","author":"DS Rudich","year":"2013","unstructured":"Rudich DS, Curcio CA, Wasserstein M, Brodie SE (2013) Inner macular hyperreflectivity demonstrated by optical coherence tomography in Niemann\u2013Pick disease. JAMA Ophthalmol. 131(9):1244\u20131246","journal-title":"JAMA Ophthalmol."},{"key":"939_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/0002-9394(75)90327-X","volume":"80","author":"J Libert","year":"1975","unstructured":"Libert J, Toussaint D, Guiselings R (1975) Ocular findings in Niemann\u2013Pick disease. Am J Ophthalmol 80:991\u20131002","journal-title":"Am J Ophthalmol"},{"key":"939_CR11","first-page":"366","volume":"12","author":"MR Robb","year":"1973","unstructured":"Robb MR, Kuwabara T (1973) The ocular pathology of type a Niemann Pick disease: a light and electron microscopic study. Invest Ophthalmol 12:366\u2013373","journal-title":"Invest Ophthalmol"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.mcn.2009.10.007","volume":"43","author":"T Claudepierre","year":"2010","unstructured":"Claudepierre T, Paques M, Simonutti M, Buard I, Sahel J, Maue RA (2010) Lack of Niemann\u2013Pick type C1 induces age-related degeneration in the mouse retina. Mol Cell Neurosci 43:164\u2013176","journal-title":"Mol Cell Neurosci"},{"key":"939_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13023-015-0348-0","volume":"10","author":"G Palladino","year":"2015","unstructured":"Palladino G, Loizzo S, Fortuna A, Canterini S, Palombi F, Erickson RP, Mangia F, Fiorenza MT (2015) Visual evoked potentials of Niemann\u2013Pick type C1 mice reveal an impairment of the visual pathway that is rescued by 2-hydroxypropyl-\u00df-cyclodextrin. Orphanet J Rare Dis 10:133","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"939_CR14","doi-asserted-by":"publisher","first-page":"e0133032","DOI":"10.1371\/journal.pone.0133032","volume":"10","author":"BX Wu","year":"2015","unstructured":"Wu BX, Fan J, Boyer NP, Jenkins RW, Koutalos Y, Hannun YA (2015) Lack of acid sphingomyelinase induces age\u2014related retinal degeneration. PLoS ONE 10(7):e0133032","journal-title":"PLoS ONE"},{"issue":"2","key":"939_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10545-005-5671-5","volume":"28","author":"H Pavl\u016f-Pereira","year":"2005","unstructured":"Pavl\u016f-Pereira H, Asfaw B, Poupctov\u00e1 H, Ledvinov\u00e1 J, Sikora J, Vanier MT, Sandhoff K, Zeman J, Novotn\u00e1 Z, Chudoba D, Elleder M (2005) Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis 28(2):203\u2013227","journal-title":"J Inherit Metab Dis"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0939-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-018-0939-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0939-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T11:02:28Z","timestamp":1567249348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-018-0939-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1007\/s10792-018-0939-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"16 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}